Literature DB >> 25406520

A nuclear chocolate box: the periodic table of nuclear medicine.

Philip J Blower1.   

Abstract

Radioisotopes of elements from all parts of the periodic table find both clinical and research applications in radionuclide molecular imaging and therapy (nuclear medicine). This article provides an overview of these applications in relation to both the radiological properties of the radionuclides and the chemical properties of the elements, indicating past successes, current applications and future opportunities and challenges for inorganic chemistry.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25406520      PMCID： PMC6205633          DOI： 10.1039/c4dt02846e

Source DB:  PubMed          Journal:  Dalton Trans        ISSN： 1477-9226            Impact factor:   4.390


  148 in total

1.  A comparison of 4 radionuclides conjugated to antibodies for single-cell kill.

Authors:  Rosana B Michel; Martin W Brechbiel; M Jules Mattes
Journal:  J Nucl Med       Date:  2003-04       Impact factor: 10.057

Review 2.  An overview of targeted alpha therapy.

Authors:  Young-Seung Kim; Martin W Brechbiel
Journal:  Tumour Biol       Date:  2011-12-06

3.  Development and clinical performance of an automated, portable tungsten-178/tantalum-178 generator.

Authors:  J L Lacy; W W Layne; G W Guidry; M S Verani; R Roberts
Journal:  J Nucl Med       Date:  1991-11       Impact factor: 10.057

Review 4.  Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography.

Authors:  Philip W Miller; Nicholas J Long; Ramon Vilar; Antony D Gee
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

5.  Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with (111)indium, (67)gallium, or (90)yttrium.

Authors:  R Ochakovskaya; L Osorio; D M Goldenberg; M J Mattes
Journal:  Clin Cancer Res       Date:  2001-06       Impact factor: 12.531

6.  Total body scanning with strontium-85 in the diagnosis of metastatic bone disease.

Authors:  W J Simpson; R P Orange
Journal:  Can Med Assoc J       Date:  1965-12-11       Impact factor: 8.262

7.  New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr.

Authors:  Nadine Di Bartolo; Alan M Sargeson; Suzanne V Smith
Journal:  Org Biomol Chem       Date:  2006-07-19       Impact factor: 3.876

Review 8.  The mechanism of 67Ga localization in malignant disease.

Authors:  R E Weiner
Journal:  Nucl Med Biol       Date:  1996-08       Impact factor: 2.408

9.  44Sc-DOTA-BN[2-14]NH2 in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET?

Authors:  E Koumarianou; N S Loktionova; M Fellner; F Roesch; O Thews; D Pawlak; S C Archimandritis; R Mikolajczak
Journal:  Appl Radiat Isot       Date:  2012-08-23       Impact factor: 1.513

10.  55Cobalt complexes with pendant carbohydrates as potential PET imaging agents.

Authors:  Cara L Ferreira; Suzanne Lapi; Jennifer Steele; David E Green; Thomas J Ruth; Michael J Adam; Chris Orvig
Journal:  Appl Radiat Isot       Date:  2007-06-26       Impact factor: 1.513
View more
  27 in total

Review 1.  A brief overview of metal complexes as nuclear imaging agents.

Authors:  Douglas S MacPherson; Kimberly Fung; Brendon E Cook; Lynn C Francesconi; Brian M Zeglis
Journal:  Dalton Trans       Date:  2019-10-07       Impact factor: 4.390

Review 2.  α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1.

Authors:  Sophie Poty; Lynn C Francesconi; Michael R McDevitt; Michael J Morris; Jason S Lewis
Journal:  J Nucl Med       Date:  2018-03-15       Impact factor: 10.057

3.  Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes.

Authors:  Giuseppe Floresta; Siham Memdouh; Truc Pham; Michelle T Ma; Philip J Blower; Robert C Hider; Vincenzo Abbate; Agostino Cilibrizzi
Journal:  Dalton Trans       Date:  2022-08-30       Impact factor: 4.569

4.  Imaging zinc trafficking in vivo by positron emission tomography with zinc-62.

Authors:  George Firth; Zilin Yu; Joanna J Bartnicka; David Parker; Jana Kim; Kavitha Sunassee; Hannah E Greenwood; Fahad Al-Salamee; Maite Jauregui-Osoro; Alberto Di Pietro; Joanna Guzman; Philip J Blower
Journal:  Metallomics       Date:  2022-10-18       Impact factor: 4.636

5.  Advancing Chelation Strategies for Large Metal Ions for Nuclear Medicine Applications.

Authors:  Aohan Hu; Justin J Wilson
Journal:  Acc Chem Res       Date:  2022-03-01       Impact factor: 24.466

Review 6.  Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy-Model, vector, and radionuclide selection.

Authors:  Lukas M Carter; Sophie Poty; Sai Kiran Sharma; Jason S Lewis
Journal:  J Labelled Comp Radiopharm       Date:  2018-03-30       Impact factor: 1.921

7.  64Cu PET Imaging of the CXCR4 Chemokine Receptor Using a Cross-Bridged Cyclam Bis-Tetraazamacrocyclic Antagonist.

Authors:  Benjamin P Burke; Cecilia S Miranda; Rhiannon E Lee; Isaline Renard; Shubhanchi Nigam; Gonçalo S Clemente; Thomas D'Huys; Torsten Ruest; Juozas Domarkas; James A Thompson; Timothy J Hubin; Dominique Schols; Christopher J Cawthorne; Stephen J Archibald
Journal:  J Nucl Med       Date:  2019-06-14       Impact factor: 11.082

8.  Opportunities and challenges for metal chemistry in molecular imaging: from gamma camera imaging to PET and multimodality imaging.

Authors:  Richard Southworth; Rafael Torres Martin de Rosales; Levente K Meszaros; Michelle T Ma; Gregory E D Mullen; Gilbert Fruhwirth; Jennifer D Young; Cinzia Imberti; Julia Bagunya-Torres; Erica Andreozzi; Philip J Blower
Journal:  Adv Inorg Chem       Date:  2015-11-16       Impact factor: 3.282

Review 9.  Reaction of [18F]Fluoride at Heteroatoms and Metals for Imaging of Peptides and Proteins by Positron Emission Tomography.

Authors:  Kymberley R Scroggie; Michael V Perkins; Justin M Chalker
Journal:  Front Chem       Date:  2021-06-23       Impact factor: 5.221

10.  Py-Macrodipa: A Janus Chelator Capable of Binding Medicinally Relevant Rare-Earth Radiometals of Disparate Sizes.

Authors:  Aohan Hu; Eduardo Aluicio-Sarduy; Victoria Brown; Samantha N MacMillan; Kaelyn V Becker; Todd E Barnhart; Valery Radchenko; Caterina F Ramogida; Jonathan W Engle; Justin J Wilson
Journal:  J Am Chem Soc       Date:  2021-06-30       Impact factor: 16.383
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.